Short Interest in ALPS Group Inc Ordinary Share (NASDAQ:ALPS) Increases By 117.9%

ALPS Group Inc Ordinary Share (NASDAQ:ALPS) was the target of a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 31,101 shares, an increase of 117.9% from the June 30th total of 14,273 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 450,688 shares, the short-interest ratio is currently 0.1 days.

ALPS Group Inc Ordinary Share Price Performance

Shares of NASDAQ:ALPS traded down $0.01 during trading on Wednesday, reaching $0.46. The company had a trading volume of 474 shares, compared to its average volume of 69,579. The business’s fifty day moving average is $0.62. The firm has a market cap of $75.88 million, a price-to-earnings ratio of 1.38 and a beta of -0.12. ALPS Group Inc Ordinary Share has a twelve month low of $0.45 and a twelve month high of $15.00.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of ALPS Group Inc Ordinary Share in a report on Monday, July 6th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has a consensus rating of “Sell”.

ALPS Group Inc Ordinary Share Company Profile

ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.